melanoma |
ecromeximab |
As nouns the difference between melanoma and ecromeximab
is that
melanoma is a dark-pigmented, usually malignant tumor arising from a melanocyte and occurring most commonly in the skin while
ecromeximab is a chimeric monoclonal antibody being developed for the treatment of malignant melanoma.
malignant |
ecromeximab |
As nouns the difference between malignant and ecromeximab
is that
malignant is while
ecromeximab is a chimeric monoclonal antibody being developed for the treatment of malignant melanoma.
As an adjective malignant
is harmful, malevolent, injurious.
chimeric |
ecromeximab |
As an adjective chimeric
is like a chimera.
As a noun ecromeximab is
a chimeric monoclonal antibody being developed for the treatment of malignant melanoma.